Skip to content

Stryker Injectable Cement

by Stryker

510(k) K060763

Stryker Injectable Cement is a Class II device made by Stryker, cleared under FDA 510(k) K060763 on 22 Sep 2006, active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK060763 Date22 Sep 2006ClearedStatusActive

Official records

Recalls

1 recall · FDA

    • Terminated Z-2054-2013 FDA Class II initiated 30 Jul 2013

    Stryker received reports of the desiccant bag in the kit leaking silica gel granulate. This could increase exposure to anesthesia during surgical delay up to 60 minutes or inadvertent implantation of silica gel granulate which could cause foreign body reaction including inflammation and might lead to the need for revision surgery.

Timeline

2 dated events

  1. Cleared FDA 510(k) K060763
  2. Recall initiated FDA recalls Z-2054-2013

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GXP
Device class
Class II
Regulation
21 CFR Part 882.5300
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code GXP (Methyl Methacrylate For Cranioplasty).

Other devices from Stryker Corp.

See all devices from Stryker Corp. →